Access, convenience, and personalization are reshaping how patients obtain hormone treatment, and the estrogen replacement therapy market is adapting through new channels and formats. Valued at USD 11.9 billion in 2025, the market is projected to reach USD 12.5 billion in 2026 and USD 19.4 billion by 2034, growing at a CAGR of 5.7% during the forecast period 2026–2034. Key players include...